About FoRx Therapeutics
Next-Generation Therapeutics FoRx Therapeutics is a privately held clinical-stage biotechnology company pioneering precision therapeutics targeting DNA Replication Stress in treatment-resistant cancers.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-A
Global Headquarters
Basel, Switzerland
Year Founded
2019
Team Size
11-50
Tracked Since
Oct 1, 2026
Web & Domain Identity
Official Website
forxtherapeutics.com
Domain Registered Date
Nov 19, 2019
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $50,000,000 · Series-A
fundraisingfox.com
- Capital Raise
Raised $10,867,000 · Seed
- Milestone
Website domain registered
forxtherapeutics.com
- Milestone
Company founded
Basel, Switzerland
Investors & Backers
EQT Life Sciences
M Ventures
Novartis Venture Fund
Omega Funds
Pfizer Venture Investments
Funding History
Series-A
· Dec 18, 2025
$50,000,000 fundraisingfox.com
Seed
· Apr 22, 2020
$10,867,000 Source
Founders & Leadership
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026